Findings opposed to use of Chloroquine + macrolide (Azithromycin or clarithromycin) as COVID-19 intervention
-
From multinational registry of patients hospitalized between 12/20/19 and 4/14/20, individuals treated with Chloroquine + macrolide had a higher risk of in-hospital mortality compared to an untreated control group
-
From multinational registry of patients hospitalized between 12/20/19 and 4/14/20, individuals treated with Chloroquine + macrolide had a higher risk of clinically significant ventricular arrhythmia compared to an untreated control group
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Learn After
Hazard ratios for ventricular arrhythmia among COVID-19 patients given different antimalarial and macrolide therapies from multinational registry of patients hospitalized between 12/20/19 and 4/14/20
Hazard ratios for in-hospital mortality among COVID-19 patients given different antimalarial and macrolide therapies from multinational registry of patients hospitalized between 12/20/19 and 4/14/20